RULE NO.:RULE TITLE:
64B18-16.005Content of Residency Program - Reports
PURPOSE AND EFFECT: The Board proposes the rule amendment in order to incorporate the revised form.
SUMMARY: The revised form will be incorporated into the rule.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:
The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the agency.
The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 461.005, 461.014(4) FS.
LAW IMPLEMENTED: 456.072(1)(j), (k), (l), 461.013(1)(g), (h), (i), 461.014 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Wm. Freeman Miller, Executive Director, Board of Podiatric Medicine, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257
THE FULL TEXT OF THE PROPOSED RULE IS:
64B18-16.005 Content of Residency Program – Reports.
On July 1 of each year, each Residency Program Director shall provide the Board with information regarding each podiatric resident using the Podiatric Resident Hospital Report form DH-MQA 1140 (revised 11/2013 7/2009), hereby adopted and incorporated by reference, that can be obtained from the Board of Podiatric Medicine’s website at http://www.doh.state.fl.us/mqa/podiatry/index.html.
Rulemaking Authority 461.005, 461.014(4) FS. Law Implemented 456.072(1)(j), (k), (l), 461.013(1)(g), (h), (i), 461.014 FS., Chapter 2005-98, Laws of Florida. History–New 11-24-80, Formerly 21T-16.05, 21T-16.005, 61F12-16.005, Amended 1-4-96, Formerly 59Z-16.005, Amended 12-2-03, 11-27-05, 10-5-09,_________.
NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Podiatric Medicine
NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Podiatric Medicine
DATE PROPOSED RULE APPROVED BY AGENCY HEAD: November 15, 2013
DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: December 3, 2013
Document Information
- Comments Open:
- 12/19/2013
- Summary:
- The revised form will be incorporated into the rule.
- Purpose:
- The Board proposes the rule amendment in order to incorporate the revised form.
- Rulemaking Authority:
- 461.005, 461.014(4) FS.
- Law:
- 456.072(1)(j), (k), (l), 461.013(1)(g), (h), (i), 461.014 FS.
- Contact:
- Wm. Freeman Miller, Executive Director, Board of Podiatric Medicine, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257.
- Related Rules: (1)
- 64B18-16.005. Content of Residency Program - Reports